How the biotech downturn is already affecting drug startups
Bio Pharma Dive
FEBRUARY 14, 2022
At an industry conference Monday, a group of venture investors noted changes in how long biotechs are taking to raise money, and a shifting outlook among investors who specialize in shepherding young companies to an IPO.
Let's personalize your content